Professor at Tulane University
Dr. Abdel-Mageed is a Professor of Urology at Tulane University School of Medicine, the Director of Molecular Oncology Research at Tulane University Health Sciences Center, the Zimmermann Endowed Professor of Cancer Research at the Tulane Cancer Center, and an adjunct professor in the Department of Pharmacology, the Center for Stem Cell Research and Regenerative Medicine, and the Graduate Program in Biomedical Sciences at Tulane. A former practicing veterinarian, he received his D.V.M. from the University of Khartoum in Sudan (1983), his M.S. (1989) and Ph.D. (1993) in Molecular Physiology and Toxicology from Kansas State University. Upon completing his postdoctoral fellowship in Tulane’s Department of Pharmacology (1994), he became a research instructor of pharmacology in 1996, subsequently joining the Department of Urology in 1997. While his long-standing translational research interests focus on molecular determinants of prostate cancer progression and prostate cancer health disparities, his current research also focuses on understanding the role of tumor-derived exosomes in mediating prostate cancer progression, with special emphasis on racial disparity of prostate cancer.
Dr. Abdel-Mageed is a Professor of Urology at Tulane University School of Medicine, the Director of Molecular Oncology Research at Tulane University Health Sciences Center, the Zimmermann Endowed Professor of Cancer Research at the Tulane Cancer Center, and an adjunct professor in the Department of Pharmacology, the Center for Stem Cell Research and Regenerative Medicine, and the Graduate Program in Biomedical Sciences at Tulane. A former practicing veterinarian, he received his D.V.M. from the University of Khartoum in Sudan (1983), his M.S. (1989) and Ph.D. (1993) in Molecular Physiology and Toxicology from Kansas State University. Upon completing his postdoctoral fellowship in Tulane’s Department of Pharmacology (1994), he became a research instructor of pharmacology in 1996, subsequently joining the Department of Urology in 1997. While his long-standing translational research interests focus on molecular determinants of prostate cancer progression and prostate cancer health disparities, his current research also focuses on understanding the role of tumor-derived exosomes in mediating prostate cancer progression, with special emphasis on racial disparity of prostate cancer.
Salamat Dr. Maha
I just joined the group of ASAPA.
Dr. Mohamed Khairi
Nice job .. proud of😂